login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
SANOFI-ADR (SNY) Stock News
NASDAQ:SNY -
US80105N1054
-
ADR
47.65
USD
+0.49 (+1.04%)
Last: 9/11/2025, 8:14:54 PM
47.3
USD
-0.35 (-0.73%)
Pre-Market:
9/12/2025, 4:54:05 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
SNY Latest News, Press Relases and Analysis
All
Press Releases
4 days ago - By: Investor's Business Daily
- Mentions:
DNTH
ARGX
AZN
Why Dianthus Therapeutics, Up 47% In Four Weeks, Just Surged Again
4 days ago - By: Zacks Investment Research
- Mentions:
REGN
LLY
NKTR
NKTR Shares Surge 38.2% in a Week: Here's What You Should Know
4 days ago - By: Benzinga
- Mentions:
IOT
TSEM
ABM
COP
...
Roblox To Rally Around 34%? Here Are 10 Top Analyst Forecasts For Monday
4 days ago - By: Benzinga
- Mentions:
STNG
VEEV
AFYA
USCB
This Veeva Systems Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
7 days ago - By: The Motley Fool
- Mentions:
NKTR
Why Nektar Therapeutics Rippled Higher This Week
8 days ago - By: Investor's Business Daily
- Mentions:
REGN
Sanofi Tumbles As New Eczema Drug Lags Dupixent's 'Compelling Bar'
8 days ago - By: Zacks Investment Research
- Mentions:
REGN
ADPT
AKRO
SNY Down Despite Eczema Candidate Meeting Goal in Phase III Study
8 days ago - By: Zacks Investment Research
- Mentions:
BMY
NVO
TEVA
TEVA Stock Up More Than 19% in a Month: Buy, Sell or Hold the Stock?
9 days ago - By: Zacks Investment Research
- Mentions:
REGN
AZN
MRK
MRK Posts Cholesterol Drug Data, Focus Shifts Back to Its Pipeline
11 days ago - By: Zacks Investment Research
- Mentions:
ADPT
AKRO
ALGS
Sanofi Gets FDA Nod for Wayrilz in Immune Thrombocytopenia
14 days ago - By: Yahoo Finance
Sanofi (SNY)’s Sarclisa Gets EMA Nod for Multiple Myeloma
15 days ago - By: Zacks Investment Research
- Mentions:
AZN
MRK
Will Weak Gardasil Sales Continue to Be a Drag on MRK's Top Line?
a month ago - By: Yahoo Finance
- Mentions:
UNH
CNC
OSCR
ELV
...
Solar, biotech, and health insurance stocks are rising on Friday: here's why
a month ago - By: Zacks Investment Research
- Mentions:
REGN
Can Eylea HD and Dupixent Profits Revive Regeneron Stock?
a month ago - By: Zacks Investment Research
- Mentions:
AMGN
RIGL
SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease
a month ago - By: Yahoo Finance
- Mentions:
NVAX
Novavax Ups Outlook, Eyes Stronger Nuvaxovid Sales
a month ago - By: Zacks Investment Research
- Mentions:
BMRN
GMAB
IMCR
BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View
a month ago - By: The Motley Fool
- Mentions:
REGN
VKTX
2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top Analysts
a month ago - By: Zacks Investment Research
- Mentions:
REGN
Regeneron Stock Rises on Q2 Earnings and Sales Beat, Eylea HD Sales Up
a month ago - By: Zacks Investment Research
- Mentions:
AZN
MRK
AMGN
AZN Q2 Earnings Meet Estimates, Sales Beat as Key Drugs Outperform
Please enable JavaScript to continue using this application.